CS
PRAH

Cannell & Spears’s PRA Health Sciences, Inc. PRAH Stock Holding History

Cannell & Spears’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,427
Closed -$372K – 250
2021
Q1 		$372K Sell
2,427
-819
-25% -$111K 0.03% 163
2020
Q4 		$407K Sell
3,246
-124
-4% -$13.9K 0.03% 151
2020
Q3 		$342K Hold
3,370
– – 0.03% 161
2020
Q2 		$328K Sell
3,370
-88
-3% -$8.19K 0.03% 155
2020
Q1 		$287K Buy
+3,458
New +$337K 0.04% 159

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Cannell & Spears's PRAH Position: Q2 2021 in Review

Cannell & Spears sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 2,427 shares — an estimated $372K sold.

Cannell & Spears first reported a position in PRAH in Q1 2020 and held it in 5 quarters. The position peaked at $407K in Q4 2020. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Cannell & Spears reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Cannell & Spears sold 2,427 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $372K.
  • Cannell & Spears first reported a position in PRA Health Sciences, Inc. in Q1 2020 and held it in 5 quarters.
  • Cannell & Spears's PRA Health Sciences, Inc. position peaked at $407K in Q4 2020.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Cannell & Spears's 13F filing for Q2 2021, filed 9 Aug 2021.